➤ Careful history and examination may reveal a constellation of musculoskeletal conditions associated with generalized joint laxity, including shoulder instability, posterolateral rotatory instability of the elbow, wrist ganglia, thumb base pathology, hip labral pathology, and patellar and ankle instability. ➤ Subtle but highly suggestive findings associated with generalized joint laxity may be recognized on radiographs or magnetic resonance imaging that can impact the clinician’s decision-making. ➤ Increasing evidence has suggested that clinical outcomes of various surgical procedures around the shoulder, hip, knee, and ankle may be impacted in patients with generalized joint laxity. Surgeons should counsel these patients accordingly to manage expectations. ➤ Patients presenting to orthopaedic specialists should be queried about symptoms and injuries in other joints to identify patients with generalized joint laxity in order to initiate early management and injury prevention protocols.
29 November 2022 in Current Reviews in Musculoskeletal Medicine
Purpose of Review The current landscape of treating anterior cruciate ligament (ACL) tears is rapidly evolving with the advent of the bridge-enhanced ACL restoration (BEAR). BEAR is a novel approach to restore the ACL in lieu of conventional reconstruction. BEAR has recently been approved for post-market use by all orthopaedic surgeons for midsubstance or proximal ACL tears. This article provides a review of the indications and outcomes of BEAR, graduating from the Trial 1 stage to the post-market stage, current operative techniques, and the postoperative rehabilitation protocol for BEAR. Recent Findings Current research demonstrates similar postoperative patient-reported outcome measures and functional outcomes following BEAR compared to ACL reconstruction in clinical trials. Combining all three BEAR trials, there was an aggregate re-tear rate of 15%. Our post-market published BEAR data shows non-inferior short-term postoperative PROMs and functional outcomes as well as zero re-tears. Summary The early- and mid-term results of BEAR show that it is a potential alternative to ACLR for specific patient groups.